Zeltiq Aesthetics

What Zeltiq Aesthetics does

Zeltiq Aesthetics is a US-based medical device company that developed and commercializes proprietary cryolipolysis technology for non-invasive reduction of unwanted fat tissue. Its core product line centers on CoolSculpting and CoolSculpting Elite, which deliver controlled cooling to selectively freeze and permanently eliminate treated fat cells (cited clinical fat-layer reduction of 20-25%), and on CoolTone, an FDA-cleared magnetic muscle stimulation device for strengthening and toning the abdomen, buttocks, and thighs. All products are FDA-cleared for specific anatomical indications, and the franchise claims over 17 million CoolSculpting treatments performed worldwide.

The company distributes exclusively through a global network of certified healthcare providers — dermatologists, plastic surgeons, aesthetic clinics, and med-spas — using a B2B2C go-to-market in which patient acquisition is driven through the coolsculpting.com consumer site, before-and-after patient galleries, and the Allē loyalty and provider-directory platform, with Cherry financing offered to reduce out-of-pocket friction. Treatments are priced per area on a consultation-determined basis, and the Allē program functions as a recurring patient-retention and financing overlay on top of the underlying one-time-per-treatment device economics.

Zeltiq was founded in 2005 and previously traded on NASDAQ (ZLTQ) before being taken private via Allergan's approximately $2.48 billion acquisition in 2017; AbbVie subsequently acquired Allergan in 2020, and Zeltiq now operates as a wholly-owned subsidiary of AbbVie with operational alignment to its North Chicago, Illinois parent headquarters. The CoolSculpting brand, the Allē loyalty program, and the CoolTone line remain commercially active under the AbbVie/Allergan Aesthetics umbrella.

Name

Zeltiq Aesthetics

Legal name

Zeltiq Aesthetics

Website

https://zeltiq.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

251–500 employees

Short description

Zeltiq Aesthetics is a US medical device company that develops FDA-cleared cryolipolysis (CoolSculpting/CoolSculpting Elite) and magnetic muscle stimulation (CoolTone) systems, distributed globally through certified healthcare providers, dermatology practices, and med-spas for non-invasive fat reduction and muscle toning, and now operates as a subsidiary of AbbVie.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Body Contouring & Non-Invasive Aesthetic Recovery (e.g., Lymphatic Drainage) (HSADAKAM)

akta.pro secondary industries

Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices) (CRABAAAJ)

Keywords

• Non-invasive fat reduction
• Cryolipolysis technology
• Body contouring devices
• Medical aesthetics equipment
• FDA-cleared treatments

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Treatment Procedures: Revenue generated from CoolSculpting and CoolTone treatments performed by certified healthcare providers at aesthetic clinics and medical facilities. Patients pay per treatment session based on areas treated.
2. Allē Loyalty Program: Consumer loyalty program that drives patient acquisition and retention for CoolSculpting treatments. Offers savings and payment plan options through Cherry financing.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Zeltiq Aesthetics develops and commercializes non-invasive medical devices for fat reduction and muscle toning based on proprietary cryolipolysis (controlled cooling) and magnetic muscle stimulation technologies. Its flagship systems—CoolSculpting, CoolSculpting Elite, and CoolTone—are deployed through a network of certified healthcare providers, aesthetic clinics, dermatology practices, and med-spas who administer treatments to patients seeking non-surgical body contouring. The company also operates the Allē consumer loyalty program in partnership with Cherry financing.

Differentiator

Problem solved

Functional benefit

Brands

• Allē: Loyalty program for CoolSculpting treatments offering payment plans and savings.

Products and services

• CoolSculpting Elite FDA-cleared cryolipolysis system that freezes and permanently eliminates treated fat cells from the body without surgery. Treats visible fat bulges in 9 areas including abdomen, flanks, chin, thighs, upper arms, back fat, bra fat, and banana roll. Clinical studies show up to 20-25% fat layer reduction in treated areas.
• CoolSculpting Original FDA-cleared cryolipolysis treatment system that permanently freezes away treated fat and naturally eliminates fat cells from the body. Backed by clinical research with over 17 million treatments performed worldwide.
• CoolTone FDA-cleared magnetic muscle stimulation device for strengthening, toning, and firming of abdomen, buttocks, and thigh muscles in adults aged 22 and older. Induces muscle contractions to enhance muscle performance and can support rehabilitation therapy and muscle retraining.
• Allē Loyalty Program Loyalty program for CoolSculpting that helps patients save on treatments and offers payment plan options through Cherry financing with APR as low as 0% subject to eligibility and credit score. Also provides an online directory to help patients locate certified CoolSculpting providers.

Quantifiable outcome

• 20-25% fat layer reduction in treated areas
• +2 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• CherrycoreGTM or Marketing PartnerCherry provides patient financing and payment plan options for CoolSculpting treatments through the Allē program. Offers APR starting at 0% subject to eligibility and credit score, helping patients manage treatment costs.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Cutera: Cutera markets truSculpt and other energy-based body-contouring devices to dermatologists and aesthetic practices, providing a direct non-invasive fat-reduction alternative to CoolSculpting.
• BTL Group: BTL markets EmSculpt, EmSculpt NEO, and EmFace, the most direct non-invasive body-contouring and muscle-toning competitors to CoolSculpting and CoolTone, sold through the same medical-aesthetics provider channel.
• InMode: InMode sells BodyTite, Evolve, and Morpheus8 platforms for non-invasive and minimally invasive body contouring and skin remodeling, competing head-to-head with CoolSculpting in dermatology and plastic-surgery practices.
• Cynosure: Cynosure offers laser- and energy-based body-contouring and skin-tightening systems (e.g., SculpSure, TempSure) used by the same aesthetic provider base that administers CoolSculpting treatments.

Emerging players

• Venus Concept: Venus Concept offers energy-based body-contouring and skin-tightening systems targeting the same med-spa and aesthetic clinic customers as CoolSculpting, often at lower price points for emerging practices.
• Revance Therapeutics: Revance sells injectable aesthetics (Daxxify, RHA fillers) that compete for the same aesthetic-provider wallet share and patient demand for minimally invasive body and facial treatments.

Others

• Lumenis: Lumenis provides energy-based aesthetic and surgical devices used by the same dermatology and plastic-surgery customers, making it an adjacent ecosystem player rather than a direct CoolSculpting competitor.

Regional players

• Sientra: Sientra focuses on breast aesthetics and is expanding into body-contouring-adjacent categories, competing for the same plastic-surgery provider accounts that purchase CoolSculpting systems.

Broad incumbents

• Evolus: Evolus markets the Jeuveau neurotoxin and is expanding into adjacent aesthetics indications, competing for the same elective-procedure patient base that uses CoolSculpting.
• Solta Medical: Solta (Thermage, Fraxel, Clear+Brilliant) is a broader aesthetics-device incumbent selling skin-tightening and resurfacing platforms that frequently sit alongside CoolSculpting within the same provider menus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/zeltiq
• Facebookfacebook.com/113934451961571
• LinkedInlinkedin.com/company/zeltiq

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zeltiq Aesthetics